+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Osteomyelitis Drug"

Osteomyelitis - Pipeline Insight, 2024 - Product Thumbnail Image

Osteomyelitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Osteomyelitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Osteomyelitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Osteomyelitis Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Osteomyelitis Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • August 2020
  • 131 Pages
  • Global
From
Osteomyelitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteomyelitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 55 Pages
  • Global
From
Osteomyelitis (Infectious Disease) - Drugs In Development, 2021 - Product Thumbnail Image

Osteomyelitis (Infectious Disease) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 55 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Osteomyelitis is an infection of the bone and bone marrow caused by bacteria, fungi, or other microorganisms. Infectious Diseases Drugs are used to treat this condition. These drugs are typically antibiotics, antifungals, or antivirals, depending on the type of infection. They are used to reduce inflammation, reduce pain, and prevent further spread of the infection. Commonly prescribed drugs include cephalosporins, fluoroquinolones, and vancomycin. In some cases, surgery may be necessary to remove the infected bone or tissue. The Osteomyelitis Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of pharmaceutical companies that develop and manufacture drugs to treat osteomyelitis. These companies are typically large, multinational corporations that specialize in the research and development of new drugs. Examples of companies in this market include Pfizer, Merck, GlaxoSmithKline, and Sanofi. Show Less Read more